secwatch.observer — SEC 8-K summary
======================================

Issuer:     NutriBand Inc. (NTRB)
CIK:        0001676047
Form:       8-K
Filed at:   2024-01-11T23:59:59+00:00
Accession:  0001213900-24-003023
Event type: other_material
Sentiment:  positive
Materiality: 0.80
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nutriband signs commercial development & clinical supply agreement with Kindeva for Aversa Fentanyl patch
--------------------------------------------------------------------------------

- Kindeva to perform commercial process development & supply clinical materials for FDA abuse liability study.
- Agreement replaces prior feasibility deal; moves AVERSA Fentanyl toward NDA filing.
- AVERSA Fentanyl estimated peak annual US sales $80M-$200M per Health Advances 2022 market analysis.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1676047/000121390024003023/0001213900-24-003023-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1676047/000121390024003023/ea191528-8k_nutriband.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-003023

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer